Our study demonstrates how HHIP, through restricting Hh activation, can modulate the dynamic changes of myofibroblasts and protect alveologenesis, providing a theoretical rationale for the clinical trial of HHIP-Fc recombinant protein for BPD and BPD-associated emphysema. Here, HHIP is linked to pulmonary emphysema.